Definium Therapeutics, Inc.
DFTX
$22.01
$0.854.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -206.01% | -69.12% | -71.88% | -12.23% | 38.06% |
| Total Depreciation and Amortization | -- | -- | -201.93% | -203.74% | -205.82% |
| Total Amortization of Deferred Charges | -- | -- | -41.51% | -69.02% | -78.93% |
| Total Other Non-Cash Items | 920.28% | 32.22% | 40.42% | -81.36% | -118.09% |
| Change in Net Operating Assets | 438.26% | 382.21% | 295.21% | 170.75% | -232.85% |
| Cash from Operations | -57.45% | -66.26% | -53.26% | -37.66% | -35.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.53% | -- | -- | -- | -- |
| Cash from Investing | 132.53% | -- | -- | -- | -- |
| Total Debt Issued | 320.00% | 320.00% | 320.00% | 68.00% | -33.33% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 223.56% | 1.42% | -97.79% | -57.19% | -55.29% |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -108.32% | 1.94% | 96.87% | 47.51% | 18.81% |
| Cash from Financing | 219.69% | 5.56% | -90.00% | -53.10% | -55.41% |
| Foreign Exchange rate Adjustments | 138.10% | 76.67% | 87.50% | 123.08% | -148.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 206.01% | -109.14% | -255.04% | -266.15% | -237.87% |